SHELTON, CONNECTICUT / ACCESS Newswire / August 18, 2025 / NanoViricides, Inc., a publicly traded company (NYSE American:NNVC ...

For a few dozen people in the world, the downside of living with a rare immune condition comes with a surprising ...

Health experts say the best time to get a COVID booster shot is in the early fall, with mid-September through October ...

A rare immune disorder has inspired a potential universal antiviral therapy. By mimicking the mutation s unique inflammation ...

In what sounds like the plot from a sci-fi movie, scientists have isolated an incredibly rare immune mutation to create a universal antiviral treatment. Only present in a few dozen people ...

There are a small group of people in the world who carry a unique feature in their DNA: a genetic mutation called ISG15 that ...

Scientists created mRNA inhaler that makes cells produce antiviral proteins. It protected cells from flu and Zika, and ...

Despite current warning labels, oseltamivir is not linked to increased risk for neuropsychiatric events in pediatric patients ...

Scientists at Columbia University are developing a universal antiviral. This treatment aims to protect against many viruses, including influenza and COVID-19. The therapy is inspired by a rare genetic ...

How to get Paxlovid if you have health insurance What to know before you begin Make sure you have the following on hand: A list of any medications you’re currently taking, as COVID antiviral drugs can ...

There are two antiviral pills authorized by the U.S. Food and Drug Administration to treat COVID-19 at home: Pfizer's Paxlovid for people 12 and older, and Merck's molnupiravir for adults.

The direct-acting antiviral targets in the hepatitis C virus replication cycle. NS3/4A protease inhibitors target the NS3/4A protease enzyme which is needed for the virus to develop the proteins ...